N@N

ISIS, RDEN, RMTR, MIPS, ARRY, SAM Are Seasonally Ripe To Go Down In the Next Five Weeks

February 16, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ISIS PHARMACEUTICALS INCORPORATED (NASDAQ:ISIS), ELIZABETH ARDEN INC (NASDAQ:RDEN), RAMTRON INTERNATIONAL CORP (NASDAQ:RMTR), MIPS TECHNOLOGIES INC (NASDAQ:MIPS), ARRAY BIOPHARMA INC (NASDAQ:ARRY), BOSTON BEER COMPANY INC-A (NYSE:SAM) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

     Symbol     Company                             Expected Return     Odds                    By The Following Date
     ISIS       ISIS PHARMACEUTICALS INCORPORATED     -4.61%              91.67% (11 of 12)       Tuesday, February 21st 2012
     RDEN       ELIZABETH ARDEN INC                 -3.85%              91.67% (11 of 12)       Tuesday, February 21st 2012
     RMTR       RAMTRON INTERNATIONAL CORP          -5.39%              91.67% (11 of 12)       Monday, February 20th 2012
     MIPS       MIPS TECHNOLOGIES INC               -6.61%              75.00% (9 of 12)        Tuesday, February 21st 2012
     ARRY       ARRAY BIOPHARMA INC                 -3.41%              90.91% (10 of 11)       Monday, February 20th 2012
     SAM        BOSTON BEER COMPANY INC-A           -3.42%              87.50% (14 of 16)       Wednesday, February 22nd 2012

ISIS PHARMACEUTICALS INCORPORATED (NASDAQ:ISIS) - Isis Pharmaceuticals, Inc. engages in the discovery and development of a new class of drugs called antisense drugs using antisense technology, a novel drug discovery platform to generate a broad pipeline of first-in-class drugs. It develops antisense drugs focused on treating cardiovascular, metabolic and severe neurodegenerative diseases, and cancer for systemic, local, and inhaled delivery. The company has commercialized antisense drugs and has 22 drugs in development. Isis Pharmaceuticals has strategic alliances with GlaxoSmithKline, Genzyme Corporation, Archemix Corp., Alnylam Pharmaceuticals, Inc., and Xenon Pharmaceuticals Inc. The company was founded in 1989 and is based in Carlsbad, California.

ELIZABETH ARDEN INC (NASDAQ:RDEN) - Elizabeth Arden, Inc., a prestige beauty products company, sells fragrances, and skin care and cosmetic products to retailers and other outlets in the United States and internationally. The company offers various fragrance products for men and women, including perfumes, colognes, eau de toilette, eau de parfum, body sprays, and gift sets, as well as bath and body products based on a particular fragrance, such as soaps, deodorants, body lotions, gels, creams, and dusting powder. It sells its fragrance products under various brands, such as Elizabeth Taylors White Diamonds and Passion, curious Britney Spears, fantasy Britney Spears and Britney Spears believe, with Love...Hilary Duff, Danielle by Danielle Steel, M by Mariah Carey, Usher, Curve, Giorgio Beverly Hills, Lucky, PS Fine Cologne for Men, Design and White Shoulders, Juicy Couture, Badgley Mischka, Rocawear, Alberta Ferretti, Alfred Sung, Nannette Lepore, Geoffrey Beene, Halston, Bob Mackie, and GANT primarily to department stores, mass retailers, distributors, perfumeries, boutiques, and travel retail outlets. The companys skin care products include moisturizers, creams, lotions, and cleansers, which are sold under the Ceramide, PREVAGE, Eight Hour Cream, and Intervene brands. It sells its skin care products primarily in prestige department and specialty stores, perfumeries, and travel retail outlets. The companys cosmetic products consist of the Elizabeth Arden brand foundations, lipsticks, mascaras, eye shadows, and powders that are sold primarily in prestige and specialty stores, perfumeries, and travel retail outlets. It also sells its products through its e-commerce site at elizabetharden.com. Elizabeth Arden, Inc. has a strategic partnership with Bazooka Candy Brands for the launch of Mariah Carey's fragrance collection, Lollipop Bling. The company is headquartered in Miramar, Florida.

RAMTRON INTERNATIONAL CORP (NASDAQ:RMTR) - Ramtron International Corporation, a fabless semiconductor company, designs, develops, and markets specialized semiconductor memory, microcontroller, and integrated semiconductor solutions. It integrates ferroelectric materials into semiconductor products, which enable the development of ferroelectric random access memory (F-RAM) products that merge the multiple memory technologies into a single device. The companys F-RAM product line includes various interfaces and densities, such as industry-standard serial and parallel interfaces; industry standard package types; and 4-kilobit, 16-kilobit, 64-kilobit, 256-kilobit, 1-megabit, 2-megabit, and 4-megabit densities. Its serial F-RAM devices allow more frequent data transfers over the serial bus to the processor; parallel F-RAM products are drop-in replacements for battery-backed SRAM products; and integrated F-RAM products, also known as processor companions, are single-chip solutions that replace a number of individual system components to reduce cost and board space. The company serves various customers for a range of applications in the metering, computing and information systems, automotive, communications, consumer and industrial, scientific, and medical markets. Ramtron International sells its products through direct sales force, manufacturers representatives, and distributors in the Americas, Europe, the Asia Pacific, and Japan. The company was founded in 1984 and is headquartered in Colorado Springs, Colorado.

MIPS TECHNOLOGIES INC (NASDAQ:MIPS) - MIPS Technologies, Inc. provides industry-standard processor architectures and cores that power various home entertainment, communications, networking, and portable multimedia products. It licenses embedded processor intellectual property in the form of architectures and implementations. The company develops standards for 32-bit and 64-bit computing; and licenses its industry-standard MIPS32 and MIPS64 instruction-set architectures, application specific extensions, core designs, and other related intellectual property. It also offers a range of embedded processors that scale across various markets in standard, custom, semi-custom, and application-specific products. Its technology is used in mobile consumer electronics, digital entertainment, wired and wireless communications and networking, office automation, security, microcontrollers, and automotive markets. The company primarily serves global semiconductor companies and system original equipment manufacturers. It operates in the United States, Japan, the Pacific Rim, and Europe. The company was founded in 1984 and is headquartered in Sunnyvale, California.

ARRAY BIOPHARMA INC (NASDAQ:ARRY) - Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer, inflammatory, and metabolic diseases in North America, Europe, and Asia Pacific. Its programs under development pipeline include ARRY-403, a glucokinase activator for Type 2 diabetes, that is in a Phase 1 multiple ascending dose trial; ARRY-162, a MEK inhibitor for cancer that is in a Phase 1 trial; ARRY-380, an ErbB-2 inhibitor for breast cancer, which is in Phase 1 dose escalation trial; and ARRY-520, a KSP inhibitor that is in Phase 1 expansion trial in solid tumors and Phase 1/2 acute myeloid leukemia and multiple myeloma trials. The companys programs also comprise ARRY-614, a p38/Tie 2 dual inhibitor, which is in Phase 1 trial in myelodysplastic syndrome patients; ARRY-543, an ErbB family (ErbB-2/EGFR) inhibitor for solid tumors that is in Phase 1b combination trials; ARRY-797, a p38 inhibitor for subacute pain and cancer supportive care indications; and ARRY-300, an MEK that completed Phase 1 trial in healthy volunteers. It has collaborations with Celgene Corporation focusing on the discovery, development, and commercialization of novel therapeutics in cancer and inflammation; Genentech, Inc. to develop cancer programs; and AstraZeneca, PLC, which licensed the companys three MEK inhibitors for cancer, including AZD6244 (ARRY-886). The company was founded in 1998 and is headquartered in Boulder, Colorado.

BOSTON BEER COMPANY INC-A (NYSE:SAM) - The Boston Beer Company, Inc. produces and sells low alcohol beverages primarily in the United States, Canada, Europe, Israel, the Caribbean, the Pacific Rim, and Mexico. The company markets approximately 20 beers under the Samuel Adams or the Sam Adams brand names; 8 flavored malt beverage products under the Twisted Tea brand name; and 1 hard cider product under the HardCore Cider brand name. It also produces malt beverages and hard cider products under contract for third parties. The company sells its products to a network of wholesale distributors, who then sell to retailers, such as pubs, restaurants, grocery chains, package stores, stadiums, and other retail outlets. The Boston Beer Company, Inc. was founded in 1984 and is based in Boston, Massachusetts.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641